HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Iron nanoparticles injected into tumors to boost Radiation's power
Disease control Not yet recruitingThis study is testing whether injecting a new iron nanoparticle suspension directly into tumors makes radiation therapy more effective for certain solid cancers. It will enroll about 52 adults with head and neck cancer or soft tissue sarcoma who are candidates for radiation. The …
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Sichuan Enray Pharmaceutical Sciences Company • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Simple blood test could tell doctors which cancer patients will respond to immunotherapy
Diagnosis Not yet recruitingThis study aims to develop a blood test that predicts whether cancer patients will benefit from immunotherapy drugs. Researchers will analyze blood samples from 600 patients with lung cancer, melanoma, breast cancer, kidney cancer, or head/neck cancer before they start treatment.…
Matched conditions: HNSCC
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC